Log In
person
Amgen Inc
AMGN
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Human Therapeutics |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
26.91B | 95.46% |
| Human Therapeutics |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
1.28B | 4.54% |
| keyboard_arrow_down |
Human Therapeutics
Branded Pharmaceuticals
|
26.91B | 95.46% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Human Therapeutics
Pharmaceutical Patent Licensing
|
1.28B | 4.54% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||